Core Insights - Haemonetics Corporation has received CE Mark certification for its SavvyWire guidewire, which is the first sensor-guided 3-in-1 solution for Transcatheter Aortic Valve Implantation (TAVI) [8] - The SavvyWire guidewire is designed to enhance procedural efficiency by providing predictable wire performance, hemodynamic measurement, and left-ventricular pacing capabilities [8][10] - The first commercial procedures using the SavvyWire guidewire were successfully performed in Europe, specifically at CHU Bordeaux in France and Catharina Ziekenhuis Eindhoven in the Netherlands [4][8] Company Overview - Haemonetics is a global medical technology company focused on delivering innovative medical solutions aimed at improving patient outcomes [8][11] - The company has expanded its product portfolio with the acquisition of OpSens Inc. in December 2023, which included the SavvyWire guidewire [4] - Haemonetics aims to leverage its global commercial infrastructure to enhance access to critical interventional technologies across Europe, the Middle East, and Africa [5] Product Features - The SavvyWire guidewire allows for multiple procedural steps over the same guidewire, reducing the need for device exchanges and enabling continuous monitoring of cardiac hemodynamics [10] - It is engineered to support reliable left-ventricular pacing without the need for additional devices or venous access, streamlining the TAVI procedure [10] - The guidewire's capabilities are expected to raise the standard for hemodynamic measurements during TAVI, allowing for immediate procedural decision-making by physicians [11]
Haemonetics Announces CE Mark Certification for the SavvyWire® Pre-Shaped Pressure Guidewire